Economic Times | Glenmark gains 2% on USFDA nod for Hydrocortisone Butyrate Moneycontrol.com Shares of Glenmark Pharmaceuticals gained more than 2 percent in late morning trade Monday as the pharmaceutical company received USFDA's nod for its Hydrocortisone Butyrate Cream USP, 0.1 percent - a generic version of Locoid Lipocream. Glenmark Generics gets US FDA nod for hydrocortisone butyrate cream Glenmark gets another approval by USFDA: Nod for generic Hydrocortisone ... Glenmark Generics Receives Approval For Hydrocortisone Butyrate Cream USP ... |
